ERBB2 and sarcoma: An ongoing phase I/II study of second-generation HER2–CAR-T cells conducted in 19 patients with HER2-positive sarcomas showed two CRs and some disease stabilizations with evidence of tumor necrosis in patients with osteosarcoma without DLTs [182].